Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Mild cognitive impairment: baseline and longitudinal structural MR imaging measures improve predictive prognosis.

McEvoy LK, Holland D, Hagler DJ Jr, Fennema-Notestine C, Brewer JB, Dale AM; Alzheimer's Disease Neuroimaging Initiative.

Radiology. 2011 Jun;259(3):834-43. doi: 10.1148/radiol.11101975. Epub 2011 Apr 6.

2.

Alzheimer disease: quantitative structural neuroimaging for detection and prediction of clinical and structural changes in mild cognitive impairment.

McEvoy LK, Fennema-Notestine C, Roddey JC, Hagler DJ Jr, Holland D, Karow DS, Pung CJ, Brewer JB, Dale AM; Alzheimer's Disease Neuroimaging Initiative.

Radiology. 2009 Apr;251(1):195-205. doi: 10.1148/radiol.2511080924. Epub 2009 Feb 6.

3.

Relative capability of MR imaging and FDG PET to depict changes associated with prodromal and early Alzheimer disease.

Karow DS, McEvoy LK, Fennema-Notestine C, Hagler DJ Jr, Jennings RG, Brewer JB, Hoh CK, Dale AM; Alzheimer's Disease Neuroimaging Initiative.

Radiology. 2010 Sep;256(3):932-42. doi: 10.1148/radiol.10091402.

4.

Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers.

Shaffer JL, Petrella JR, Sheldon FC, Choudhury KR, Calhoun VD, Coleman RE, Doraiswamy PM; Alzheimer’s Disease Neuroimaging Initiative.

Radiology. 2013 Feb;266(2):583-91. doi: 10.1148/radiol.12120010. Epub 2012 Dec 11.

5.

Mild cognitive impairment and alzheimer disease: patterns of altered cerebral blood flow at MR imaging.

Dai W, Lopez OL, Carmichael OT, Becker JT, Kuller LH, Gach HM.

Radiology. 2009 Mar;250(3):856-66. doi: 10.1148/radiol.2503080751. Epub 2009 Jan 21.

6.

Cerebral microhemorrhage and iron deposition in mild cognitive impairment: susceptibility-weighted MR imaging assessment.

Haller S, Bartsch A, Nguyen D, Rodriguez C, Emch J, Gold G, Lovblad KO, Giannakopoulos P.

Radiology. 2010 Dec;257(3):764-73. doi: 10.1148/radiol.10100612. Epub 2010 Oct 5.

PMID:
20923870
7.

Whole-brain atrophy rate and cognitive decline: longitudinal MR study of memory clinic patients.

Sluimer JD, van der Flier WM, Karas GB, Fox NC, Scheltens P, Barkhof F, Vrenken H.

Radiology. 2008 Aug;248(2):590-8. doi: 10.1148/radiol.2482070938. Epub 2008 Jun 23.

PMID:
18574133
8.

Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment.

Fleisher AS, Sun S, Taylor C, Ward CP, Gamst AC, Petersen RC, Jack CR Jr, Aisen PS, Thal LJ.

Neurology. 2008 Jan 15;70(3):191-9. doi: 10.1212/01.wnl.0000287091.57376.65.

PMID:
18195264
9.

Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort.

Risacher SL, Saykin AJ, West JD, Shen L, Firpi HA, McDonald BC; Alzheimer's Disease Neuroimaging Initiative (ADNI).

Curr Alzheimer Res. 2009 Aug;6(4):347-61.

10.

Prognostic value of posteromedial cortex deactivation in mild cognitive impairment.

Petrella JR, Prince SE, Wang L, Hellegers C, Doraiswamy PM.

PLoS One. 2007 Oct 31;2(10):e1104.

11.

Classification of Alzheimer disease, mild cognitive impairment, and normal cognitive status with large-scale network analysis based on resting-state functional MR imaging.

Chen G, Ward BD, Xie C, Li W, Wu Z, Jones JL, Franczak M, Antuono P, Li SJ.

Radiology. 2011 Apr;259(1):213-21. doi: 10.1148/radiol.10100734. Epub 2011 Jan 19.

12.

Combining MRI and CSF measures for classification of Alzheimer's disease and prediction of mild cognitive impairment conversion.

Westman E, Muehlboeck JS, Simmons A.

Neuroimage. 2012 Aug 1;62(1):229-38. doi: 10.1016/j.neuroimage.2012.04.056. Epub 2012 May 3.

PMID:
22580170
13.

Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative.

Gomar JJ, Bobes-Bascaran MT, Conejero-Goldberg C, Davies P, Goldberg TE; Alzheimer's Disease Neuroimaging Initiative.

Arch Gen Psychiatry. 2011 Sep;68(9):961-9. doi: 10.1001/archgenpsychiatry.2011.96.

PMID:
21893661
14.

Discrimination between Alzheimer disease, mild cognitive impairment, and normal aging by using automated segmentation of the hippocampus.

Colliot O, Chételat G, Chupin M, Desgranges B, Magnin B, Benali H, Dubois B, Garnero L, Eustache F, Lehéricy S.

Radiology. 2008 Jul;248(1):194-201. doi: 10.1148/radiol.2481070876. Epub 2008 May 5.

PMID:
18458242
15.

Montreal Cognitive Assessment Memory Index Score (MoCA-MIS) as a predictor of conversion from mild cognitive impairment to Alzheimer's disease.

Julayanont P, Brousseau M, Chertkow H, Phillips N, Nasreddine ZS.

J Am Geriatr Soc. 2014 Apr;62(4):679-84. doi: 10.1111/jgs.12742. Epub 2014 Mar 17.

PMID:
24635004
16.

Analysis of regional MRI volumes and thicknesses as predictors of conversion from mild cognitive impairment to Alzheimer's disease.

Liu Y, Paajanen T, Zhang Y, Westman E, Wahlund LO, Simmons A, Tunnard C, Sobow T, Mecocci P, Tsolaki M, Vellas B, Muehlboeck S, Evans A, Spenger C, Lovestone S, Soininen H; AddNeuroMed Consortium.

Neurobiol Aging. 2010 Aug;31(8):1375-85. doi: 10.1016/j.neurobiolaging.2010.01.022. Epub 2010 May 5.

PMID:
20447732
17.

Comparative diagnostic utility of different MR modalities in mild cognitive impairment and Alzheimer's disease.

Kantarci K, Xu Y, Shiung MM, O'Brien PC, Cha RH, Smith GE, Ivnik RJ, Boeve BF, Edland SD, Kokmen E, Tangalos EG, Petersen RC, Jack CR Jr.

Dement Geriatr Cogn Disord. 2002;14(4):198-207.

18.

Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study.

Drzezga A, Lautenschlager N, Siebner H, Riemenschneider M, Willoch F, Minoshima S, Schwaiger M, Kurz A.

Eur J Nucl Med Mol Imaging. 2003 Aug;30(8):1104-13. Epub 2003 May 23.

PMID:
12764551
19.

Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment.

Tabert MH, Manly JJ, Liu X, Pelton GH, Rosenblum S, Jacobs M, Zamora D, Goodkind M, Bell K, Stern Y, Devanand DP.

Arch Gen Psychiatry. 2006 Aug;63(8):916-24.

PMID:
16894068
20.

Apolipoprotein E and gray matter volume loss in patients with mild cognitive impairment and Alzheimer disease.

Spampinato MV, Rumboldt Z, Hosker RJ, Mintzer JE; Alzheimer's Disease Neuroimaging Initiative.

Radiology. 2011 Mar;258(3):843-52. doi: 10.1148/radiol.10100307. Epub 2010 Dec 16.

PMID:
21163916
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk